232 related articles for article (PubMed ID: 33098006)
1. Prevalence of adenomyosis in endometrial cancer patients: a systematic review and meta-analysis.
Raffone A; Seracchioli R; Raimondo D; Maletta M; Travaglino A; Raimondo I; Giaquinto I; Orsini B; Insabato L; Pellicano M; Zullo F
Arch Gynecol Obstet; 2021 Jan; 303(1):47-53. PubMed ID: 33098006
[TBL] [Abstract][Full Text] [Related]
2. Histological Prognostic Factors of Endometrial Cancer in Patients with Adenomyosis: A Systematic Review and Meta-Analysis.
Raffone A; Travaglino A; Raimondo D; Maletta M; Salucci P; Santoro A; Zullo F; Zannoni GF; Casadio P; Seracchioli R; Mollo A
Pathobiology; 2022; 89(3):127-134. PubMed ID: 35051948
[TBL] [Abstract][Full Text] [Related]
3. Impact of adenomyosis on the prognosis of patients with endometrial cancer.
Raimondo D; Raffone A; Travaglino A; Maletta M; Casadio P; Ambrosio M; Chiara Aru A; Santoro A; Franco Zannoni G; Insabato L; Mollo A; Zullo F; Seracchioli R
Int J Gynaecol Obstet; 2022 May; 157(2):265-270. PubMed ID: 34228822
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Patients with Endometrial Cancer and Adenomyosis.
Casadio P; Raffone A; Maletta M; Travaglino A; Raimondo D; Raimondo I; Santoro A; Paradisi R; Zannoni GF; Mollo A; Seracchioli R
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638402
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities?
Machida H; Maeda M; Cahoon SS; Scannell CA; Garcia-Sayre J; Roman LD; Matsuo K
Arch Gynecol Obstet; 2017 Jun; 295(6):1459-1468. PubMed ID: 28444512
[TBL] [Abstract][Full Text] [Related]
6. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
Szubert M; Kozirog E; Wilczynski J
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206475
[TBL] [Abstract][Full Text] [Related]
7. Malignant changes in adenomyosis in patients with endometrial adenocarcinoma: A case series.
Mao X; Zheng W; Mao W
Medicine (Baltimore); 2017 Oct; 96(43):e8336. PubMed ID: 29069006
[TBL] [Abstract][Full Text] [Related]
8. Adenomyosis and Endometrial Cancer: Literature Review.
Habiba M; Pluchino N; Petignat P; Bianchi P; Brosens IA; Benagiano G
Gynecol Obstet Invest; 2018; 83(4):313-328. PubMed ID: 29874641
[TBL] [Abstract][Full Text] [Related]
9. The effect of adenomyosis on endometrial cancer: a university hospital-based cohort study.
Celik E; Goksever Celik H; Sozen H; Onder S; Tosun OA; Topuz S; Salihoglu MY
J Obstet Gynaecol; 2022 Jan; 42(1):158-165. PubMed ID: 34895006
[TBL] [Abstract][Full Text] [Related]
10. Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis.
Matsuo K; Moeini A; Machida H; Scannell CA; Casabar JK; Kakuda M; Adachi S; Garcia-Sayre J; Ueda Y; Roman LD
Ann Surg Oncol; 2016 Mar; 23(3):959-67. PubMed ID: 26542589
[TBL] [Abstract][Full Text] [Related]
11. The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.
Kok VC; Tsai HJ; Su CF; Lee CK
Int J Gynecol Cancer; 2015 Jul; 25(6):968-76. PubMed ID: 25893280
[TBL] [Abstract][Full Text] [Related]
12. Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging.
Khalifa MA; Atri M; Klein ME; Ghatak S; Murugan P
Semin Ultrasound CT MR; 2019 Aug; 40(4):358-363. PubMed ID: 31375175
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 30 patients with atypical glandular hyperplasia or malignant transformation in foci of adenomyosis].
Liu YT; Wang S; Shi HH; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2020 Jul; 55(7):471-475. PubMed ID: 32842251
[No Abstract] [Full Text] [Related]
14. Ectopic Endometrium: The Pathologist's Perspective.
Camboni A; Marbaix E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681634
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of co-existent adenomyosis on outcomes and tumor characteristics of endometrial cancer: A meta-analysis.
An M; Duan H; Zhang Y
J Obstet Gynaecol Res; 2020 Sep; 46(9):1851-1863. PubMed ID: 32686169
[TBL] [Abstract][Full Text] [Related]
16. The impact of uterine adenomyosis on the histopathological risk factors and survival in patients with endometrial adenocarcinoma.
Yetimalar MH; Kilic D; Bezircioglu I; Yigit S
J Obstet Gynaecol; 2022 Aug; 42(6):2213-2219. PubMed ID: 35260040
[TBL] [Abstract][Full Text] [Related]
17. Immunological changes associated with adenomyosis: a systematic review.
Bourdon M; Santulli P; Jeljeli M; Vannuccini S; Marcellin L; Doridot L; Petraglia F; Batteux F; Chapron C
Hum Reprod Update; 2021 Jan; 27(1):108-129. PubMed ID: 33099635
[TBL] [Abstract][Full Text] [Related]
18. T2 relaxometry mapping in demonstrating layered uterine architecture: parameter optimization and utility in endometrial carcinoma and adenomyosis: a feasibility study.
Ghosh A; Singh T; Bagga R; Srinivasan R; Singla V; Khandelwal N
Br J Radiol; 2018 Jan; 91(1081):20170377. PubMed ID: 28936889
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
[TBL] [Abstract][Full Text] [Related]
20. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
